Richard W Wagner

Title: The Innovations of Richard W. Wagner

Introduction

Richard W. Wagner is a notable inventor based in Burlingame, California. He has made significant contributions to the field of biochemistry, particularly in the development of cationic lipids. With a total of two patents to his name, Wagner's work focuses on enhancing the delivery of nucleic acids and peptides into cells.

Latest Patents

Wagner's latest patents revolve around new cationic lipids and their synthesis. The first patent describes cationic lipids that are useful for transfecting nucleic acids or peptides into prokaryotic or eukaryotic cells. These lipids consist of one or two arginine, lysine, or ornithine residues linked to a lipophilic moiety. The resulting compositions allow for efficient transfer of polyanions into cells without causing significant toxicity. The second patent also focuses on cationic lipids, detailing their ability to form complexes with polyanions such as nucleic acids or peptides. This innovation similarly permits efficient transfer into cells, maintaining low toxicity levels.

Career Highlights

Richard W. Wagner is currently employed at Gilead Sciences, Inc., where he continues to advance his research in biochemistry. His work has been instrumental in developing new methods for gene delivery, which has implications for various therapeutic applications.

Collaborations

Wagner has collaborated with notable colleagues, including Kuei-Ying Lin and Jason G. Lewis. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Richard W. Wagner's contributions to the field of biochemistry through his innovative patents on cationic lipids highlight his role as a significant inventor. His work not only advances scientific understanding but also has practical applications in medicine.